A new analysis finds that 81 percent of authors whose work appeared in the Journal of American Medical Association and the New England Journal of Medicine in 2017 failed to disclose conflicts of interest in the form of industry payments.
The analysis reviewed 31 clinical trial reports from each of the two journals that were published in 2017 and identified 118 authors who, in total, received $7.48 million dollars in industry payments. The payment information came from Open Payments, a US government website where drug and device makers must report payments to physicians and health care providers. The analysis was posted as a preprint on medRxiv on January 1 and has not yet been peer-reviewed.
Of the 118 authors on the included papers, only a dozen did not receive any payments, according to the preprint. Of the 106 researchers who received payments, the payments ranged from as little as $6.36 ...
